Literature DB >> 27771324

Aspirin-exacerbated respiratory disease: Mediators and mechanisms of a clinical disease.

Katherine N Cahill1, Joshua A Boyce2.   

Abstract

Entities:  

Keywords:  Aspirin-exacerbated respiratory disease; cysteinyl leukotrienes; future targets; innate immune mechanisms; prostaglandin D(2)

Mesh：

Substances：

Year:  2016        PMID： 27771324     DOI： 10.1016/j.jaci.2016.09.025

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  8 in total

1.  The Saudi Initiative for Asthma - 2019 Update: Guidelines for the diagnosis and management of asthma in adults and children.

Authors:  Mohamed S Al-Moamary; Sami A Alhaider; Abdullah A Alangari; Mohammed O Al Ghobain; Mohammed O Zeitouni; Majdy M Idrees; Abdullah F Alanazi; Adel S Al-Harbi; Abdullah A Yousef; Hassan S Alorainy; Mohamed S Al-Hajjaj
Journal:  Ann Thorac Med       Date:  2019 Jan-Mar       Impact factor: 2.219

Review 2.  Update on Aspirin-Exacerbated Respiratory Disease.

Authors:  Katharine M Woessner
Journal:  Curr Allergy Asthma Rep       Date:  2017-01       Impact factor: 4.806

3.  Perimenstrual Asthma in Aspirin-Exacerbated Respiratory Disease.

Authors:  Ryan C Eid; Marina L Palumbo; Katherine N Cahill
Journal:  J Allergy Clin Immunol Pract       Date:  2019-09-30

4.  Effect of TGF-β1 on eosinophils to induce cysteinyl leukotriene E4 production in aspirin-exacerbated respiratory disease.

Authors:  Youngwoo Choi; Soyoon Sim; Dong-Hyun Lee; Hee-Ra Lee; Ga-Young Ban; Yoo Seob Shin; Yoon-Keun Kim; Hae-Sim Park
Journal:  PLoS One       Date:  2021-08-26       Impact factor: 3.240

5.  Comprehensive Analysis of Nasal Polyps Reveals a More Pronounced Type 2 Transcriptomic Profile of Epithelial Cells and Mast Cells in Aspirin-Exacerbated Respiratory Disease.

Authors:  Christine Bangert; Sergio Villazala-Merino; Martin Fahrenberger; Thomas Krausgruber; Wolfgang M Bauer; Victoria Stanek; Nicholas James Campion; Tina Bartosik; Tamara Quint; Guenther Regelsberger; Verena Niederberger-Leppin; Christoph Bock; Sven Schneider; Julia Eckl-Dorna
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

Review 6.  Therapeutic Options for Chronic Rhinosinusitis in N-ERD Patients.

Authors:  Rik J L van der Lans; Wytske J Fokkens; Sietze Reitsma
Journal:  Front Allergy       Date:  2021-08-24

Review 7.  Innate immune cell dysregulation drives inflammation and disease in aspirin-exacerbated respiratory disease.

Authors:  Ryan Eid; Carol H Yan; Whitney Stevens; Taylor A Doherty; Larry Borish
Journal:  J Allergy Clin Immunol       Date:  2021-08       Impact factor: 14.290

Review 8.  NSAID-induced reactions: classification, prevalence, impact, and management strategies.

Authors:  Natalia Blanca-Lopez; Victor Soriano; Elena Garcia-Martin; Gabriela Canto; Miguel Blanca
Journal:  J Asthma Allergy       Date:  2019-08-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.